Legend Biotech (LEGN) Long-Term Investments (2020 - 2024)

Legend Biotech's (LEGN) quarterly Long-Term Investments came in at $57.1 million in Q1 2025.

Analysis

Legend Biotech (LEGN) Long-Term Investments (2020 - 2024) Analysis & Trends

Legend Biotech (LEGN) has 1 years of Long-Term Investments data on file, last reported at $57.1 million in Q1 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	5.79 Bn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	9.83 Bn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-4.00 Mn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	1.77 Bn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	22.17 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	372.10 Mn
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	Legend Biotech	3.97 Bn	3.00 Bn	251.50 Mn	-

Historic Data

Download Data